nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—DRD3—autistic disorder	0.274	0.397	CbGaD
Methotrimeprazine—DRD1—autistic disorder	0.269	0.39	CbGaD
Methotrimeprazine—HTR2A—autistic disorder	0.147	0.213	CbGaD
Methotrimeprazine—DRD3—telencephalic ventricle—autistic disorder	0.00669	0.0629	CbGeAlD
Methotrimeprazine—DRD1—telencephalic ventricle—autistic disorder	0.00479	0.0451	CbGeAlD
Methotrimeprazine—HTR2C—telencephalic ventricle—autistic disorder	0.00372	0.035	CbGeAlD
Methotrimeprazine—HTR2A—cerebellar cortex—autistic disorder	0.00321	0.0302	CbGeAlD
Methotrimeprazine—DRD2—telencephalic ventricle—autistic disorder	0.00283	0.0266	CbGeAlD
Methotrimeprazine—HTR2A—pons—autistic disorder	0.00227	0.0213	CbGeAlD
Methotrimeprazine—HTR2A—telencephalic ventricle—autistic disorder	0.00187	0.0176	CbGeAlD
Methotrimeprazine—DRD5—forebrain—autistic disorder	0.00164	0.0154	CbGeAlD
Methotrimeprazine—DRD5—telencephalon—autistic disorder	0.00151	0.0142	CbGeAlD
Methotrimeprazine—CHRM5—eye—autistic disorder	0.00148	0.0139	CbGeAlD
Methotrimeprazine—ADRA1A—hindbrain—autistic disorder	0.00136	0.0128	CbGeAlD
Methotrimeprazine—DRD2—hindbrain—autistic disorder	0.00134	0.0126	CbGeAlD
Methotrimeprazine—ADRA1D—forebrain—autistic disorder	0.00131	0.0124	CbGeAlD
Methotrimeprazine—DRD1—brainstem—autistic disorder	0.0013	0.0122	CbGeAlD
Methotrimeprazine—DRD1—forebrain—autistic disorder	0.00125	0.0118	CbGeAlD
Methotrimeprazine—ADRA1D—telencephalon—autistic disorder	0.00121	0.0114	CbGeAlD
Methotrimeprazine—DRD1—telencephalon—autistic disorder	0.00115	0.0108	CbGeAlD
Methotrimeprazine—CHRM4—head—autistic disorder	0.00108	0.0101	CbGeAlD
Methotrimeprazine—DRD4—brain—autistic disorder	0.00103	0.0097	CbGeAlD
Methotrimeprazine—CHRM4—nervous system—autistic disorder	0.00102	0.0096	CbGeAlD
Methotrimeprazine—CHRM2—forebrain—autistic disorder	0.00101	0.00949	CbGeAlD
Methotrimeprazine—HTR2C—brainstem—autistic disorder	0.00101	0.00947	CbGeAlD
Methotrimeprazine—DRD3—head—autistic disorder	0.001	0.00941	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—autistic disorder	0.000982	0.00924	CbGeAlD
Methotrimeprazine—HTR2C—forebrain—autistic disorder	0.000972	0.00914	CbGeAlD
Methotrimeprazine—DRD3—nervous system—autistic disorder	0.000948	0.00892	CbGeAlD
Methotrimeprazine—DRD5—head—autistic disorder	0.000937	0.00882	CbGeAlD
Methotrimeprazine—CHRM2—telencephalon—autistic disorder	0.000927	0.00872	CbGeAlD
Methotrimeprazine—CHRM1—forebrain—autistic disorder	0.000918	0.00863	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—autistic disorder	0.000913	0.00859	CbGeAlD
Methotrimeprazine—HTR2C—telencephalon—autistic disorder	0.000893	0.00841	CbGeAlD
Methotrimeprazine—DRD5—nervous system—autistic disorder	0.000889	0.00836	CbGeAlD
Methotrimeprazine—HTR2A—hindbrain—autistic disorder	0.000881	0.00829	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—autistic disorder	0.000856	0.00805	CbGeAlD
Methotrimeprazine—CHRM1—telencephalon—autistic disorder	0.000844	0.00794	CbGeAlD
Methotrimeprazine—CHRM5—head—autistic disorder	0.000841	0.00791	CbGeAlD
Methotrimeprazine—CHRM3—forebrain—autistic disorder	0.000821	0.00773	CbGeAlD
Methotrimeprazine—CYP2D6—hindbrain—autistic disorder	0.000803	0.00755	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—autistic disorder	0.000797	0.0075	CbGeAlD
Methotrimeprazine—ADRA1A—brainstem—autistic disorder	0.000781	0.00735	CbGeAlD
Methotrimeprazine—CHRM4—brain—autistic disorder	0.00078	0.00734	CbGeAlD
Methotrimeprazine—ADRA1B—head—autistic disorder	0.000768	0.00723	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—autistic disorder	0.000768	0.00722	CbGeAlD
Methotrimeprazine—DRD2—brainstem—autistic disorder	0.000766	0.0072	CbGeAlD
Methotrimeprazine—CHRM3—telencephalon—autistic disorder	0.000755	0.00711	CbGeAlD
Methotrimeprazine—ADRA1A—forebrain—autistic disorder	0.000754	0.00709	CbGeAlD
Methotrimeprazine—ADRA1D—head—autistic disorder	0.000752	0.00707	CbGeAlD
Methotrimeprazine—DRD2—eye—autistic disorder	0.000745	0.00701	CbGeAlD
Methotrimeprazine—DRD2—forebrain—autistic disorder	0.000739	0.00695	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—autistic disorder	0.000728	0.00685	CbGeAlD
Methotrimeprazine—DRD3—brain—autistic disorder	0.000725	0.00682	CbGeAlD
Methotrimeprazine—DRD1—head—autistic disorder	0.000716	0.00674	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—autistic disorder	0.000713	0.00671	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—autistic disorder	0.000701	0.0066	CbGeAlD
Methotrimeprazine—ADRA1A—telencephalon—autistic disorder	0.000693	0.00652	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—autistic disorder	0.000686	0.00646	CbGeAlD
Methotrimeprazine—DRD2—telencephalon—autistic disorder	0.00068	0.00639	CbGeAlD
Methotrimeprazine—DRD5—brain—autistic disorder	0.000679	0.00639	CbGeAlD
Methotrimeprazine—DRD1—nervous system—autistic disorder	0.000679	0.00639	CbGeAlD
Methotrimeprazine—ADRA2C—telencephalon—autistic disorder	0.000661	0.00622	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—autistic disorder	0.000654	0.00615	CbGeAlD
Methotrimeprazine—CHRM5—brain—autistic disorder	0.000609	0.00573	CbGeAlD
Methotrimeprazine—HRH1—eye—autistic disorder	0.000589	0.00554	CbGeAlD
Methotrimeprazine—HRH1—forebrain—autistic disorder	0.000584	0.00549	CbGeAlD
Methotrimeprazine—CHRM2—head—autistic disorder	0.000577	0.00543	CbGeAlD
Methotrimeprazine—CHRM3—digestive system—autistic disorder	0.000576	0.00542	CbGeAlD
Methotrimeprazine—ADRA2A—forebrain—autistic disorder	0.000573	0.00539	CbGeAlD
Methotrimeprazine—ADRA1B—brain—autistic disorder	0.000557	0.00524	CbGeAlD
Methotrimeprazine—HTR2C—head—autistic disorder	0.000556	0.00524	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—autistic disorder	0.000547	0.00515	CbGeAlD
Methotrimeprazine—ADRA1D—brain—autistic disorder	0.000545	0.00513	CbGeAlD
Methotrimeprazine—HRH1—telencephalon—autistic disorder	0.000537	0.00505	CbGeAlD
Methotrimeprazine—HTR2C—nervous system—autistic disorder	0.000527	0.00496	CbGeAlD
Methotrimeprazine—ADRA2A—telencephalon—autistic disorder	0.000527	0.00496	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—autistic disorder	0.000527	0.00496	CbGeAlD
Methotrimeprazine—CHRM1—head—autistic disorder	0.000525	0.00494	CbGeAlD
Methotrimeprazine—DRD1—brain—autistic disorder	0.000519	0.00488	CbGeAlD
Methotrimeprazine—CYP2E1—telencephalon—autistic disorder	0.000516	0.00485	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—autistic disorder	0.000508	0.00478	CbGeAlD
Methotrimeprazine—HTR2A—brainstem—autistic disorder	0.000505	0.00475	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—autistic disorder	0.000498	0.00469	CbGeAlD
Methotrimeprazine—HTR2A—eye—autistic disorder	0.000492	0.00463	CbGeAlD
Methotrimeprazine—HTR2A—forebrain—autistic disorder	0.000487	0.00459	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—autistic disorder	0.00048	0.00451	CbGeAlD
Methotrimeprazine—CHRM3—head—autistic disorder	0.00047	0.00442	CbGeAlD
Methotrimeprazine—CYP2D6—brainstem—autistic disorder	0.00046	0.00433	CbGeAlD
Methotrimeprazine—HTR2A—telencephalon—autistic disorder	0.000448	0.00422	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—autistic disorder	0.000446	0.00419	CbGeAlD
Methotrimeprazine—CYP2D6—forebrain—autistic disorder	0.000444	0.00418	CbGeAlD
Methotrimeprazine—CYP1A2—digestive system—autistic disorder	0.000438	0.00412	CbGeAlD
Methotrimeprazine—ADRA1A—head—autistic disorder	0.000432	0.00406	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—autistic disorder	0.000429	0.00404	CbGeAlD
Methotrimeprazine—DRD2—head—autistic disorder	0.000423	0.00398	CbGeAlD
Methotrimeprazine—CHRM2—brain—autistic disorder	0.000418	0.00394	CbGeAlD
Methotrimeprazine—ADRA2C—head—autistic disorder	0.000411	0.00387	CbGeAlD
Methotrimeprazine—HRH1—digestive system—autistic disorder	0.00041	0.00385	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—autistic disorder	0.000409	0.00385	CbGeAlD
Methotrimeprazine—CYP2D6—telencephalon—autistic disorder	0.000408	0.00384	CbGeAlD
Methotrimeprazine—HTR2C—brain—autistic disorder	0.000403	0.00379	CbGeAlD
Methotrimeprazine—DRD2—nervous system—autistic disorder	0.000401	0.00377	CbGeAlD
Methotrimeprazine—Diltiazem—CACNA1C—autistic disorder	0.000396	0.0609	CrCbGaD
Methotrimeprazine—ADRA1A—central nervous system—autistic disorder	0.000394	0.00371	CbGeAlD
Methotrimeprazine—CYP2E1—digestive system—autistic disorder	0.000394	0.0037	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—autistic disorder	0.00039	0.00367	CbGeAlD
Methotrimeprazine—DRD2—central nervous system—autistic disorder	0.000386	0.00363	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—autistic disorder	0.000385	0.00362	CbGeAlD
Methotrimeprazine—CHRM1—brain—autistic disorder	0.000381	0.00358	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—autistic disorder	0.000378	0.00355	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—autistic disorder	0.000375	0.00353	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—autistic disorder	0.000367	0.00345	CbGeAlD
Methotrimeprazine—Acetophenazine—DRD1—autistic disorder	0.000359	0.0553	CrCbGaD
Methotrimeprazine—HTR2A—digestive system—autistic disorder	0.000342	0.00322	CbGeAlD
Methotrimeprazine—CHRM3—brain—autistic disorder	0.000341	0.00321	CbGeAlD
Methotrimeprazine—HRH1—head—autistic disorder	0.000334	0.00314	CbGeAlD
Methotrimeprazine—ADRA2A—head—autistic disorder	0.000328	0.00309	CbGeAlD
Methotrimeprazine—CYP2E1—head—autistic disorder	0.000321	0.00302	CbGeAlD
Methotrimeprazine—Propericiazine—DRD1—autistic disorder	0.000317	0.0488	CrCbGaD
Methotrimeprazine—HRH1—nervous system—autistic disorder	0.000317	0.00298	CbGeAlD
Methotrimeprazine—ADRA1A—brain—autistic disorder	0.000313	0.00294	CbGeAlD
Methotrimeprazine—CYP2D6—digestive system—autistic disorder	0.000312	0.00293	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—autistic disorder	0.000311	0.00293	CbGeAlD
Methotrimeprazine—DRD2—brain—autistic disorder	0.000307	0.00289	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—autistic disorder	0.000305	0.00287	CbGeAlD
Methotrimeprazine—CYP2E1—nervous system—autistic disorder	0.000304	0.00286	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—autistic disorder	0.0003	0.00282	CbGeAlD
Methotrimeprazine—ADRA2C—brain—autistic disorder	0.000298	0.0028	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—autistic disorder	0.000293	0.00276	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—autistic disorder	0.000293	0.00276	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—autistic disorder	0.000286	0.0027	CbGeAlD
Methotrimeprazine—HTR2A—head—autistic disorder	0.000279	0.00263	CbGeAlD
Methotrimeprazine—Trifluoperazine—XDH—autistic disorder	0.000272	0.0418	CrCbGaD
Methotrimeprazine—HTR2A—nervous system—autistic disorder	0.000265	0.00249	CbGeAlD
Methotrimeprazine—Trimipramine—HTR3A—autistic disorder	0.000255	0.0393	CrCbGaD
Methotrimeprazine—HTR2A—central nervous system—autistic disorder	0.000255	0.0024	CbGeAlD
Methotrimeprazine—CYP2D6—head—autistic disorder	0.000254	0.00239	CbGeAlD
Methotrimeprazine—Trimipramine—HTR1D—autistic disorder	0.000252	0.0388	CrCbGaD
Methotrimeprazine—HTR2A—cerebellum—autistic disorder	0.000249	0.00234	CbGeAlD
Methotrimeprazine—HRH1—brain—autistic disorder	0.000242	0.00228	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—autistic disorder	0.000241	0.00227	CbGeAlD
Methotrimeprazine—ADRA2A—brain—autistic disorder	0.000238	0.00224	CbGeAlD
Methotrimeprazine—CYP2E1—brain—autistic disorder	0.000233	0.00219	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—autistic disorder	0.000232	0.00218	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—autistic disorder	0.000227	0.00213	CbGeAlD
Methotrimeprazine—Triflupromazine—DRD1—autistic disorder	0.00022	0.0339	CrCbGaD
Methotrimeprazine—Clomipramine—GSTP1—autistic disorder	0.000205	0.0316	CrCbGaD
Methotrimeprazine—Acepromazine—DRD1—autistic disorder	0.000204	0.0314	CrCbGaD
Methotrimeprazine—HTR2A—brain—autistic disorder	0.000202	0.0019	CbGeAlD
Methotrimeprazine—Thioproperazine—DRD1—autistic disorder	0.000199	0.0307	CrCbGaD
Methotrimeprazine—Mesoridazine—DRD3—autistic disorder	0.000197	0.0303	CrCbGaD
Methotrimeprazine—Pipotiazine—DRD1—autistic disorder	0.000196	0.0302	CrCbGaD
Methotrimeprazine—Prochlorperazine—DRD3—autistic disorder	0.000191	0.0294	CrCbGaD
Methotrimeprazine—CYP2D6—brain—autistic disorder	0.000184	0.00173	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2A—autistic disorder	0.000173	0.0266	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD3—autistic disorder	0.000173	0.0266	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD1—autistic disorder	0.000169	0.0261	CrCbGaD
Methotrimeprazine—Propiomazine—DRD1—autistic disorder	0.000163	0.0251	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD3—autistic disorder	0.000157	0.0242	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD1—autistic disorder	0.000154	0.0238	CrCbGaD
Methotrimeprazine—Thioridazine—DRD1—autistic disorder	0.000146	0.0225	CrCbGaD
Methotrimeprazine—Perphenazine—DRD1—autistic disorder	0.000134	0.0206	CrCbGaD
Methotrimeprazine—Promazine—DRD1—autistic disorder	0.000121	0.0186	CrCbGaD
Methotrimeprazine—Acepromazine—HTR2A—autistic disorder	0.000111	0.0171	CrCbGaD
Methotrimeprazine—Clomipramine—SLC6A4—autistic disorder	0.00011	0.0169	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—autistic disorder	0.000109	0.0167	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD3—autistic disorder	0.000108	0.0167	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—autistic disorder	0.000107	0.0164	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD1—autistic disorder	0.000106	0.0164	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—autistic disorder	0.000105	0.0162	CrCbGaD
Methotrimeprazine—Trimipramine—SLC6A4—autistic disorder	0.000101	0.0156	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2A—autistic disorder	9.23e-05	0.0142	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—autistic disorder	8.88e-05	0.0137	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2A—autistic disorder	8.44e-05	0.013	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—autistic disorder	8.41e-05	0.0129	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—autistic disorder	7.95e-05	0.0122	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—autistic disorder	7.77e-05	0.012	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A4—autistic disorder	7.5e-05	0.0115	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—autistic disorder	7.48e-05	0.0115	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—autistic disorder	7.38e-05	0.0114	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—autistic disorder	7.3e-05	0.0112	CrCbGaD
Methotrimeprazine—Promazine—HTR2A—autistic disorder	6.58e-05	0.0101	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2A—autistic disorder	5.79e-05	0.00891	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—autistic disorder	5.76e-05	0.00887	CrCbGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—LEP—autistic disorder	4e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APOE—autistic disorder	4e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	3.99e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL2—autistic disorder	3.99e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—HRAS—autistic disorder	3.97e-06	2.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—POMC—autistic disorder	3.93e-06	1.99e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PRKCB—autistic disorder	3.91e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF1—autistic disorder	3.88e-06	1.97e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL2—autistic disorder	3.88e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	3.86e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—POMC—autistic disorder	3.86e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—autistic disorder	3.86e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PRKCB—autistic disorder	3.85e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—COMT—autistic disorder	3.84e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PRKCB—autistic disorder	3.84e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SERPINE1—autistic disorder	3.84e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PRKCB—autistic disorder	3.83e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GSTP1—autistic disorder	3.83e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL2—autistic disorder	3.82e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MAOA—autistic disorder	3.82e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PRKCB—autistic disorder	3.82e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—POMC—autistic disorder	3.81e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—HRAS—autistic disorder	3.81e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—autistic disorder	3.8e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TSC2—autistic disorder	3.79e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PRKCB—autistic disorder	3.78e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF1—autistic disorder	3.78e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	3.77e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	3.77e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—MAPK1—autistic disorder	3.76e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—autistic disorder	3.75e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—APC—autistic disorder	3.74e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CG—autistic disorder	3.74e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CAT—autistic disorder	3.72e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF1—autistic disorder	3.72e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—LEP—autistic disorder	3.71e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APOE—autistic disorder	3.71e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGF—autistic disorder	3.7e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	3.7e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	3.69e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	3.68e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—APC—autistic disorder	3.68e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CG—autistic disorder	3.68e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—APC—autistic disorder	3.67e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CG—autistic disorder	3.67e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APC—autistic disorder	3.66e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	3.66e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL2—autistic disorder	3.66e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	3.65e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APC—autistic disorder	3.65e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PTEN—autistic disorder	3.65e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—autistic disorder	3.64e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGF—autistic disorder	3.64e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGF—autistic disorder	3.63e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—HRAS—autistic disorder	3.63e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGF—autistic disorder	3.62e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	3.62e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APC—autistic disorder	3.62e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGF—autistic disorder	3.61e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	3.61e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APC—autistic disorder	3.61e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PTEN—autistic disorder	3.6e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SERPINE1—autistic disorder	3.59e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	3.58e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—HRAS—autistic disorder	3.58e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGF—autistic disorder	3.57e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGF—autistic disorder	3.56e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—POMC—autistic disorder	3.56e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	3.53e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GSTM1—autistic disorder	3.52e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	3.52e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—POMC—autistic disorder	3.51e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP19A1—autistic disorder	3.5e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—POMC—autistic disorder	3.5e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	3.5e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—POMC—autistic disorder	3.5e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL2—autistic disorder	3.49e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—POMC—autistic disorder	3.49e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—POMC—autistic disorder	3.48e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—autistic disorder	3.47e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PTEN—autistic disorder	3.44e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL2—autistic disorder	3.44e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL2—autistic disorder	3.44e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—POMC—autistic disorder	3.44e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—POMC—autistic disorder	3.43e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1—autistic disorder	3.43e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—autistic disorder	3.42e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—autistic disorder	3.42e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—MAPK1—autistic disorder	3.41e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1—autistic disorder	3.37e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GPX1—autistic disorder	3.37e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1—autistic disorder	3.36e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	3.36e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1—autistic disorder	3.35e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	3.35e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APC—autistic disorder	3.35e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—MAPK1—autistic disorder	3.35e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1—autistic disorder	3.34e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	3.34e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	3.33e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—autistic disorder	3.32e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGF—autistic disorder	3.31e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1—autistic disorder	3.31e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1—autistic disorder	3.3e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	3.3e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.29e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	3.29e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PTEN—autistic disorder	3.28e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTEN—autistic disorder	3.27e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—COMT—autistic disorder	3.26e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SERPINE1—autistic disorder	3.25e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTP1—autistic disorder	3.24e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PTEN—autistic disorder	3.24e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PTEN—autistic disorder	3.24e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MAOA—autistic disorder	3.23e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—HRAS—autistic disorder	3.23e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—HRAS—autistic disorder	3.22e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	3.2e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SERPINE1—autistic disorder	3.2e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—POMC—autistic disorder	3.19e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	3.19e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	3.17e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CAT—autistic disorder	3.15e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	3.14e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	3.14e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MTHFR—autistic disorder	3.11e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL2—autistic disorder	3.11e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—HRAS—autistic disorder	3.1e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—autistic disorder	3.09e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—autistic disorder	3.09e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1—autistic disorder	3.07e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	3.05e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—autistic disorder	3.04e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—HRAS—autistic disorder	3.02e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL2—autistic disorder	2.98e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTM1—autistic disorder	2.98e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PLA2G4A—autistic disorder	2.98e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	2.97e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—autistic disorder	2.97e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MAPK1—autistic disorder	2.96e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MAPK1—autistic disorder	2.92e-06	1.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PTEN—autistic disorder	2.92e-06	1.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	2.91e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL2—autistic disorder	2.9e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—autistic disorder	2.89e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTEN—autistic disorder	2.89e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—autistic disorder	2.89e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2—autistic disorder	2.86e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GPX1—autistic disorder	2.85e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—autistic disorder	2.84e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PTEN—autistic disorder	2.81e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MAPK1—autistic disorder	2.8e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—autistic disorder	2.79e-06	1.41e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—HRAS—autistic disorder	2.74e-06	1.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PTEN—autistic disorder	2.73e-06	1.38e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—HRAS—autistic disorder	2.69e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—HRAS—autistic disorder	2.69e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PTEN—autistic disorder	2.69e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—HRAS—autistic disorder	2.68e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HRAS—autistic disorder	2.67e-06	1.35e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MAPK1—autistic disorder	2.67e-06	1.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTEN—autistic disorder	2.65e-06	1.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HRAS—autistic disorder	2.65e-06	1.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	2.64e-06	1.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2—autistic disorder	2.63e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	2.63e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MAPK1—autistic disorder	2.63e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—autistic disorder	2.63e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—autistic disorder	2.62e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CG—autistic disorder	2.61e-06	1.32e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2—autistic disorder	2.59e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2—autistic disorder	2.59e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—autistic disorder	2.58e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2—autistic disorder	2.58e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—autistic disorder	2.57e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2—autistic disorder	2.57e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—autistic disorder	2.56e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—autistic disorder	2.56e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2—autistic disorder	2.54e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2—autistic disorder	2.54e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—autistic disorder	2.53e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—autistic disorder	2.52e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—autistic disorder	2.49e-06	1.26e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PTEN—autistic disorder	2.48e-06	1.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	2.45e-06	1.24e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—autistic disorder	2.45e-06	1.24e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PTEN—autistic disorder	2.44e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTEN—autistic disorder	2.44e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PTEN—autistic disorder	2.43e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PTEN—autistic disorder	2.43e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PTEN—autistic disorder	2.42e-06	1.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PTEN—autistic disorder	2.39e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PTEN—autistic disorder	2.39e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HRAS—autistic disorder	2.38e-06	1.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK1—autistic disorder	2.38e-06	1.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—autistic disorder	2.36e-06	1.19e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HRAS—autistic disorder	2.35e-06	1.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—autistic disorder	2.35e-06	1.19e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK1—autistic disorder	2.28e-06	1.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—autistic disorder	2.28e-06	1.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HRAS—autistic disorder	2.25e-06	1.14e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—autistic disorder	2.25e-06	1.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK1—autistic disorder	2.22e-06	1.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PTEN—autistic disorder	2.22e-06	1.12e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CG—autistic disorder	2.21e-06	1.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	2.19e-06	1.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—autistic disorder	2.15e-06	1.09e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HRAS—autistic disorder	2.14e-06	1.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HRAS—autistic disorder	2.11e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HRAS—autistic disorder	2.11e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—autistic disorder	2.11e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—autistic disorder	2.05e-06	1.04e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—autistic disorder	2.02e-06	1.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—autistic disorder	2.02e-06	1.02e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK1—autistic disorder	2.01e-06	1.02e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK1—autistic disorder	1.98e-06	1e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—autistic disorder	1.98e-06	1e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK1—autistic disorder	1.98e-06	1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK1—autistic disorder	1.97e-06	9.98e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK1—autistic disorder	1.97e-06	9.95e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK1—autistic disorder	1.95e-06	9.85e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	1.94e-06	9.82e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HRAS—autistic disorder	1.91e-06	9.66e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HRAS—autistic disorder	1.83e-06	9.28e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—autistic disorder	1.83e-06	9.24e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	1.8e-06	9.13e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HRAS—autistic disorder	1.78e-06	9.02e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HRAS—autistic disorder	1.75e-06	8.88e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—autistic disorder	1.75e-06	8.88e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTEN—autistic disorder	1.73e-06	8.75e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—autistic disorder	1.71e-06	8.63e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—autistic disorder	1.68e-06	8.5e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—autistic disorder	1.68e-06	8.5e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HRAS—autistic disorder	1.62e-06	8.19e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HRAS—autistic disorder	1.59e-06	8.05e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HRAS—autistic disorder	1.59e-06	8.04e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HRAS—autistic disorder	1.58e-06	8.01e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HRAS—autistic disorder	1.58e-06	7.99e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HRAS—autistic disorder	1.56e-06	7.91e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HRAS—autistic disorder	1.56e-06	7.89e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—autistic disorder	1.55e-06	7.83e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—autistic disorder	1.52e-06	7.71e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—autistic disorder	1.52e-06	7.69e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—autistic disorder	1.52e-06	7.67e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—autistic disorder	1.51e-06	7.64e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—autistic disorder	1.5e-06	7.57e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—autistic disorder	1.49e-06	7.55e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTEN—autistic disorder	1.46e-06	7.41e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HRAS—autistic disorder	1.45e-06	7.33e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—autistic disorder	1.39e-06	7.01e-06	CbGpPWpGaD
